- Abstract Number: 0602
Labor Impact of SARS-COV-2 Pandemic in Argentine Rheumatologists
- Abstract Number: 1409
Lack of Conventional Acinar Cells in the Salivary Gland Following Anti PD-L1 and anti-PD-1 Immune Checkpoint Inhibitor Therapy
- Abstract Number: 1254
Lack of Efficacy of Early Treatment with Hydroxychloroquine in a Group of Hispanics with Primary Sjögren’s Syndrome
- Abstract Number: 1406
LAG-3+ T Cells Are Diminished in Active Psoriatic Arthritis Patients and Their Restoration in Vitro Is Mediated by TNF Inhibitors
- Abstract Number: 2033
Large-scale Examination of Longitudinal Skin Gene Expression and Its Associations with Skin Thickness in Systemic Sclerosis
- Abstract Number: 0019
Lasting COVID-19 Impacts on US Rheumatology Practices
- Abstract Number: 0937
Late Cardiovascular Outcomes in Children with Kawasaki Disease: A Population-based Cohort Study
- Abstract Number: 0858
Leflunomide: A Safe and Effective Alternative in Systemic Lupus Erythematosus
- Abstract Number: 1915
Leptin Plays a Critical Role in Modulating Dermal Adipose Tissue, Inflammation and Skin Fibrosis
- Abstract Number: 1585
Lessons Learned Through Rapid Quality Improvement for Telehealth Implementation in an Academic Rheumatology Practice During the COVID-19 Pandemic
- Abstract Number: 1509
Leukocyte Telomere Length and Childhood Onset of Systemic Lupus Erythematosus in the Black Women’s Experiences Living with Lupus (BeWELL) Study
- Abstract Number: 1899
Life Expectancy a Swiss Cohort of Patients with Ankylosing Spondylitis: A 35-Year Follow-up Study
- Abstract Number: 1198
Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease Among Patients with Rheumatoid Arthritis
- Abstract Number: 0037
Lipoprotein-associated Phospholipase A2: A New Biomarker for Lymphoma Development in Sjögren’s Syndrome
- Abstract Number: 0700
Lipoxin A4 Induces Lipid Class Switching and Inflammation Resolution at the Genomic Level in Human Osteoarthritis
- Abstract Number: 0703
Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Studies Supporting a Pro-Chondrogenic Effect
- Abstract Number: 0254
LLDAS (Low Lupus Disease Activity State) and Remission Prevent Damage Accrual in Systemic Lupus Erythematosus (SLE) Patients in a Primarily Mestizo Cohort
- Abstract Number: 1485
LNA043, a Novel Cartilage Regenerative Treatment for Osteoarthritis: Results from a First-In-Human Trial in Patients with Knee Osteoarthritis
- Abstract Number: 0705
lncRNA H19 and Micro RNA 675-3p Are Altered by Visfatin During Osteogenesis
- Abstract Number: 0298
Local Genetic Ancestry Associations with Clinical Features of Systemic Lupus Erythematosus
- Abstract Number: 2051
Localized versus Systemic Granulomatosis with Polyangiitis: Data from the French Vasculitis Study Group Database
- Abstract Number: 0749
Locating Cellular Subsets in Rheumatoid Arthritis Synovium Using CO-Detection by IndEXing (CODEX)
- Abstract Number: 0052
Loneliness and Social Isolation Are Important Social Determinants Among Patients from Minority Communities with Rheumatic Diseases
- Abstract Number: 1914
Long Non-coding RNA HOTAIR Induces GLI2 Expression Through Notch Signalling in Systemic Sclerosis Dermal Fibroblasts
- Abstract Number: L08
Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Febuxostat versus Allopurinol Streamlined Trial (on Behalf of the FAST Investigators)
- Abstract Number: 0720
Long Term Efficacy and Safety of Triamcinolone Hexacetonide versus Triamcinolone Acetonide Intraarticular Injection for Juvenile Idiopathic Arthritis
- Abstract Number: 1094
Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis
- Abstract Number: 0810
Long Term Remission Rates from a Biologic Clinic: 12 Year Real World Data
- Abstract Number: 1845
Long-Term Clinical Outcomes of Patients with Lupus Nephritis Treated with an Intensified B-Cell Depletion Protocol: A Matched Case-Control Study
- Abstract Number: 1479
Long-Term Effectiveness of Canakinumab in Autoinflammatory Diseases – Interim Analysis of the CAPS Subgroup from the RELIANCE Registry
- Abstract Number: 1632
Long-Term Efficacy and Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes – First Interim Analysis of the FMF-TRAPS-HIDS/MKD Subgroup of the RELIANCE Registry
- Abstract Number: 1486
Long-term Efficacy and Safety of Intra-articular Sprifermin in Patients with Knee Osteoarthritis: Results from the 5-Year Forward Study
- Abstract Number: 1626
Long-Term Follow-Up of Renal Transplantation Due to Lupus Nephritis. Single Universitary Center Experience
- Abstract Number: 1688
Long-term Hearing Loss, Anxiety and Neurodevelopmental Outcomes Following Kawasaki Disease: A Population-based Cohort Study
- Abstract Number: 0811
Long-term Opioid Use in Patients with Rheumatoid Arthritis Treated with Sarilumab
- Abstract Number: 1668
Long-Term Outcomes in Children Born to Anti-Ro and/or Anti-La Positive Mothers
- Abstract Number: 0907
Long-term Outcomes with Filgotinib, an Oral Selective Janus Kinase 1 Inhibitor: 100-week Data from an Open-label Extension (OLE) Study in Patients with Active Psoriatic Arthritis (PsA)
- Abstract Number: 0212
Long-Term Safety and Effectiveness of Upadacitinib or Adalimumab in Patients with Rheumatoid Arthritis: Results at 72 Weeks
- Abstract Number: 0210
Long-term Safety and Efficacy of Sarilumab over 5 Years in Patients with Rheumatoid Arthritis Refractory to Tumor Necrosis Factor Inhibitors
- Abstract Number: 0240
Long-term Safety and Efficacy of Sarilumab over 5 Years in Patients with Rheumatoid Arthritis with 1 or >1 Prior Tumor Necrosis Factor Inhibitor Failures
- Abstract Number: 1630
Long-term Safety of Tildrakizumab in Patients with Moderate to Severe Plaque Psoriasis: Incidence of Confirmed Major Adverse Cardiovascular Events Through 3 Years (148 Weeks) from Two Phase 3 Trials
- Abstract Number: 1155
Long-term Safety Profile of Anakinra in Patients with Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 0892
Long-Term Safety Profile of Ixekizumab Treatment in Patients with Axial Spondyloarthritis
- Abstract Number: 1392
Long-Term Tolerability of Aminaphtone in Raynaud’s Phenomenon Secondary to Systemic Sclerosis
- Abstract Number: 1003
Long-term Weight Changes and Risk of Rheumatoid Arthritis Among Women in a Prospective Cohort: A Marginal Structural Model Approach
- Abstract Number: 0953
Long-term Xanthine Oxidase Inhibitor Treat to Target Urate Lowering Therapy Coordinately Re-wires the Mononuclear Leukocyte Mitochondrial and Inflammatory Proteome in Gout
- Abstract Number: 1507
Longitudinal Analysis of ANA Assay Performance in SLE from the SLICC Inception Cohort
- Abstract Number: 1805
Longitudinal Analysis of IFN Status and Disease Characteristics in SLE
- Abstract Number: 0307
Longitudinal Analysis of the Patient Pathways to Diagnosis of Psoriatic Arthritis
- Abstract Number: 1451
Longitudinal Assessment of Anti-beta 2 Glycoprotein in SLE
- Abstract Number: 1812
Longitudinal Blood DNA Methylation in a Multi-ethnic Cohort of SLE Patients
- Abstract Number: 1750
Longitudinal Change in the Central Nervous System Pain Response After Treatment with Certolizumab or Placebo. a Post-hoc Analysis from the Pre-CEPRA Trial
- Abstract Number: 0713
Longitudinal Effectiveness of Abatacept in JIA: Results from an Ongoing JIA Registry
- Abstract Number: 1992
Longitudinal Evaluation of Axonal Dysfunction, Neuronal Markers and Serum Cytokines in Childhood-onset Systemic Lupus Erythematosus
- Abstract Number: 1299
Longitudinal Patterns of Anxiety Symptomology Among Patients with Systemic Lupus Erythematosus (SLE) Remain Stable over Time and Do Not Associate with SLE Disease Activity
- Abstract Number: 1715
Longitudinal Patterns of Remission in Real-World Early Rheumatoid Arthritis Patients: Results from the Canadian Early Arthritis Cohort (CATCH)
- Abstract Number: 1260
Longitudinal Relationships Between Depression, Anxiety and Cognition in Lupus
- Abstract Number: 0302
Longitudinal Study of Acute SLE Flare Reveals Dynamic Changes in Multiple Immune Cell Subsets
- Abstract Number: 1114
Longitudinally Assessed Structural Abnormalities on MRI and Relative Contributions to Risk of Incident Radiographic Knee Osteoarthritis over 10 Years of Follow-up
- Abstract Number: 1670
Low Copy Number of Long C4 Genes Is a Genetic Risk Factor for Childhood Onset SLE (cSLE) but Is Associated with Higher Age of Disease Onset
- Abstract Number: 1277
Low Cost Composite Markers to Differentiate Infection from Disease Activity in a Febrile Patient with Systemic Lupus Erythematosus
- Abstract Number: 1777
Low Dose Aspirin to Prevent Pre-eclampsia in SLE Pregnancies – Counselling Helps to Realize Our Full Potential
- Abstract Number: 0559
Low Frequency of ANA/DFS70 Pattern Positive Result in a Large Cohort of Autoimmune/autoinflammatory Diseases Compared with First Degree Relatives and Healthy Controls Evaluated in a Single Hospital from Colombia
- Abstract Number: 1924
Low Immunogenicity in Patients with Giant Cell Arteritis Treated with Tocilizumab: 3-Year Results from the Randomized Controlled Portion and the Open-Label Follow-Up of a Phase 3 Trial
- Abstract Number: 0435
Low Incidence of Coronavirus Disease 2019 (COVID-19) Infection in Patients on Biologic Infusion Therapies at a Community Rheumatology Practice
- Abstract Number: 0938
Low Preconceptional Complement Level Is Related with an Adverse Obstetric Outcome in a Multicentric Cohort of Pregnancy in Patients with APS and aPL Positivity
- Abstract Number: PP02
Low- and Hi-Tech Tools for Enhancing Patient-Hospital Care Team Communication in the Context of Rare Disease
- Abstract Number: 0699
Lumbar Spine Stenosis Treatment : Is Surgery Better Than Medical Treatment in Afro-Descendant Populations ?
- Abstract Number: 1297
Lupus Antibodies in Relation to Malignancy
- Abstract Number: 1680
Lupus Anticoagulant as a Predictor of Adverse Outcomes in Children with Venous Thromboembolism
- Abstract Number: 1298
Lupus Damage Free-Survival by Age at Diagnosis: A Retrospective Incident Lupus Cohort
- Abstract Number: 1829
Lupus Disease Activity After Cessation of Anifrolumab Treatment During the Phase 2b MUSE Trial Follow-up Period
- Abstract Number: 0247
Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients with Systemic Lupus Erythematosus
- Abstract Number: 1770
Lupus Low Disease Activity State Protects Against Pre-Term Birth
- Abstract Number: 0250
Lupus Nephritis and Renal Outcomes in African-Americans: The Accelerating Medicines Partnership Cohort Experience
- Abstract Number: 0273
Lupus Nephritis Is Associated with a Reduced Prevalence of Fibromyalgia
- Abstract Number: 0462
Lupus-like Autoimmunity and Increased Interferon Response in Patients with STAT3-deficient Hyper-IgE Syndrome
- Abstract Number: 0792
LY294002 Improves the Collagen-induced Arthritis by Inducing Neutrophil Apoptosis
- Abstract Number: 1557
Lymphatics as a Biomarker of Joint Physiology: Near-Infrared Imaging of Indocyanine Green Identifies Novel Routes of Lymphatic Drainage from Metacarpophalangeal Joints in Healthy Human Hands
- Abstract Number: 0460
Lymphocyte Clonal Expansion Distinguishes Different Forms of Uveitis
- Abstract Number: 0184
Lymphomas Complicating Rheumatoid Arthritis: Results of a French Multi-Centre Case-Control Study
ACR Convergence 2020
November 5-9, 2020. All Virtual.